Global health science marketing and communications firm, SCORR Marketing, has released a new study, in partnership with Applied Clinical Trials, evaluating the extent to which collaborations occur in the life sciences what influences these collaborations.
Report
“To fight the growing complexity and costs of drug development, drug sponsors are turning to a variety of strategies, one of which is collaborating on research and development (R&D),” said Anne-Marie Hess, senior strategic advisor at SCORR. “To help the industry better understand this strategy, we gathered information about attitudes toward collaborative R&D, its benefits and risks, which groups participate in such collaborations and why some partnerships are more productive than others.”